Compounding Ownership & Advocacy

Talk to Your Pharmacist Podcast Interview with Shawn Hodges, PharmD

Dr. Hillary Blackburn interviewed Innovation Compounding’s President and CEO, Shawn Hodges, PharmD to talk about compounding pharmacy leadership and ownership. ⁣⁣⁣⁣⁣Conversation topics include:⁣⁣⁣

• Compounding Pharmacy Ownership
• Key Issues Affecting Compounding
• Supporting Prescribers
• And more….

Listen now!

Release date: 12 August 2019
The Talk to Your Pharmacist is a podcast for pharmacists, student pharmacists, and others across the country to hear from industry leaders about their leadership stories and current healthcare topics.⁣⁣

The Talk to Your Pharmacist is a podcast for pharmacists, student pharmacists, and others across the country to hear from industry leaders about their leadership stories and current healthcare topics.⁣⁣

Host – Hillary Blackburn, PharmD
www.pharmacyadvisory.com
Connect on LinkedIn
@talktoyourpharmacist for Instagram and Facebook
@HillBlackburn Twitter

Connect with Us

If you have any questions or would like additional information, please contact Innovation Compounding at 1-800-547-1399, Monday-Friday, 9 a.m. to 5 p.m. EST, excluding all major holidays.

Medical Disclaimer This content is for informational and educational purposes only. It is not intended to provide medical advice or take the place of such information or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. Neither Innovation Compounding, Inc. nor the publisher of this content takes responsibility for possible health consequences of any person or persons reading or following the information in this educational content. All viewers of this content, especially those taking prescription or over-the-counter medications, should consult their physicians before beginning any medication, nutritional supplement, diet, or health regimen. Innovation Compounding does not make or intend to make any claims to efficacy or safety of compounded products for specific conditions or disease states, as compounded products are not FDA-approved for these conditions.